Proceeds from website advertising help sustain Lab Tests Online. AACC is a not-for-profit organization and does not endorse non-AACC products and services.

Soluble Mesothelin-Related Peptides

Print this article
Share this page:
Also known as: SMRP
Formal name: Soluble Mesothelin-Related Peptides
Related tests: Tumor Markers

Board approvedAll content on Lab Tests Online has been reviewed and approved by our Editorial Review Board.

Article Sources

« Return to Related Pages

NOTE: This article is based on research that utilizes the sources cited here as well as the collective experience of the Lab Tests Online Editorial Review Board. This article is periodically reviewed by the Editorial Board and may be updated as a result of the review. Any new sources cited will be added to the list and distinguished from the original sources used. To access online sources, copy and paste the URL into your browser.

Sources Used in Current Review

Tan, W. (2014 April 23 Updated). Mesothelioma. Medscape Drugs and Diseases Available online at http://emedicine.medscape.com/article/280367-overview. Accessed on 6/19/16.

(2016 February 17 Revised). Malignant Mesothelioma. American Cancer Society. Available online at http://www.cancer.org/cancer/malignantmesothelioma/detailedguide/malignant-mesothelioma-malignant-mesothelioma. Accessed on 6/19/16.

Ai, J. and Stevenson, J. (2014 September). Current Issues in Malignant Pleural Mesothelioma Evaluation and Management. Oncologist. 2014 Sep; 19(9): 975–984. Available online at http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153452/. Accessed on 6/19/16.

(2016 May Updated). Mesothelioma. ARUP Consult. Available online at https://arupconsult.com/content/mesothelioma/?tab=tab_item-0. Accessed on 6/19/16.

Carletti, A. et al (2012). Soluble Mesothelin-Related Peptide in the Pleural Fluid as a Diagnostic Marker in Malignant Pleural Mesothelioma. Chest. 2012;142(4_MeetingAbstracts):494A. doi:10.1378/chest.1373488. Available online at http://journal.publications.chestnet.org/article.aspx?articleID=1375898. Accessed on 6/19/16.

Mayo Clinic Staff. (2015 October 23). Mesothelioma. Mayo Clinic. Available online at http://www.mayoclinic.org/diseases-conditions/mesothelioma/basics/definition/CON-20026157?p=1. Accessed on 6/19/16.

Opitz, I. et al (2014 March 12) Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know. European Journal of Cardio-Thoracic Surgery 46 (2014) 602–606. Available online at http://ejcts.oxfordjournals.org/content/46/4/602.full.pdf+html. Accessed on 6/19/16.

Asbestos.com. Mesothelioma Histology. Available online at https://www.asbestos.com/mesothelioma/histology.php. Accessed October 2016.

Mesothelioma.com. Types of Mesothelioma. Available online at http://www.mesothelioma.com/mesothelioma/types/. Accessed October 2016.

Sources Used in Previous Reviews

ARUP Laboratories. Soluble Mesothelin-Related Peptides (MESOMARK®). (March 2007, Issued). PDF available for download through http://www.aruplab.com. Accessed on June 17, 2008.

U.S. Food and Drug Administration, Center for Devices and Radiological Health (February 22, 2007, Updated). New Humanitarian Device Approval: Mesomark ™ - H060004. Available online at http://www.fda.gov/cdrh/mda/docs/H060004.html. Accessed on June 16, 2008.

Email interview with David Grenache, Medical Director, Special Chemistry, ARUP Laboratories, Salt Lake City, Utah. June 20, 2008.

Pacific Heart & Blood Institute. Mesomark. Available online at http://www.phlbi.org/mesomark_available.asp. Accessed June 17, 2008.

ARUP Laboratories. The Physician's Guide to Laboratory Test Selection and Interpretation: Mesothelioma. Available online at http://www.arupconsult.com/Topics/OncologicDz/Mesothelioma.html. Accessed June 17, 2008.

Fujirebio Diagnostics. FAQ: The Mesomark Assay. Available at http://www.fdi.com/mesomark/world/about/faqs.html#4. Accessed June 18, 2008.

Beyer, H. et al. Mesomark™: A Potential Test for Malignant Pleural Mesothelioma. Clinical Chemistry 2007: 53: 666-672.

Creaney, J. et al. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 2007; 62: 569-576.

U.S. Food and Drug Administration. Center for Devices and Radiological Health Guidance for Industry and FDA Staff: Humanitarian Device Exemption (HDE) Regulation: Questions and Answers. (July 18, 2006, Issued). PDF available for download at http://www.fda.gov/cdrh/ode/guidance/1381.pdf. Accessed June 16, 2008.

Fujirebio Diagnostics. Healthcare Professionals: Mesomark ® Approved for Humanitarian Use in the U.S. Available online at http://www.fdi.com/mesomark/usa/professionals/healthcare_professionals.html. Accessed June 18, 2008.

Cancer Research UK. Mesothelioma Risks and Causes. (February 5, 2008, Updated). Available online at http://www.cancerhelp.org.uk/help/default.asp?page=4395. Accessed June 20, 2008.

National Cancer Institute. Mesothelioma: Questions and Answers. (May 13, 2002, Reviewed). Available online at http://www.cancer.gov/cancertopics/factsheet/Sites-Types/mesothelioma. Accessed June 20, 2008.

(Revised 2011 June 16). How is malignant mesothelioma diagnosed? American Cancer Society [On-line information]. Available online at http://www.cancer.org/Cancer/MalignantMesothelioma/DetailedGuide/malignant-mesothelioma-diagnosed. Accessed November 2011.

(2009 March). Soluble Mesothelin-Related Peptides (MESOMARK®) for Monitoring Patients Diagnosed with Biphasic or Epithellioid Mesothelioma ARUP Technical Bulletins [On-line information]. Available online through https://www.aruplab.com. Accessed November 2011.

Tan, W. (Updated 2010 October 7). Mesothelioma. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/280367-overview. Accessed November 2011.

Wheatley-Price, P. (2010 July 10). Soluble Mesothelin-Related Peptide and Osteopontin As Markers of Response in Malignant Mesothelioma. JCO v(28) 20 [On-line information]. Available online at http://jco.ascopubs.org/content/28/20/3316.full. Accessed November 2011.

Ray, M. and Kindler, H. (2009 September). Malignant Pleural Mesothelioma, An Update on Biomarkers and Treatment. CHEST v 136 (3) [On-line information]. Available online at http://chestjournal.chestpubs.org/content/136/3/888.full. Accessed November 2011.